imatinib mesylate (Sun Pharma Global FZE)


Welcome to the PulseAid listing for the imatinib mesylate drug offered from Sun Pharma Global FZE. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sun Pharma Global FZE
NON-PROPRIETARY NAME: imatinib mesylate
SUBSTANCE NAME: IMATINIB MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-02-01
END MARKETING DATE: 0000-00-00


imatinib mesylate HUMAN PRESCRIPTION DRUG Details:

Item Descriptionimatinib mesylate from Sun Pharma Global FZE
LABELER NAME: Sun Pharma Global FZE
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/1)
START MARKETING DATE: 2016-02-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 47335-472_7f760b0e-c989-4521-9f02-45d81f1cae7a
PRODUCT NDC: 47335-472
APPLICATION NUMBER: ANDA078340

Other IMATINIB MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health Packagingimatinib mesylate
Apotex CorpImatinib Mesylate
Avera McKennan HospitalGleevec
AvKARE, Inc.Imatinib Mesylate
AvPAKImatinib Mesylate
Golden State Medical Supply, Inc.Imatinib Mesylate
Mylan Pharmaceuticals Inc.Imatinib Mesylate
NorthStar RxLLCimatinib mesylate
Novartis Pharma Produktions GmbHGleevec
Novartis Pharmaceuticals CorporationGleevec
Sun Pharma Global FZEimatinib mesylate
Teva Pharmaceuticals USA, Inc.Imatinib Mesylate